Chart analyst Frank Cappelleri goes through the charts that make this stock an attractive play.
Get this delivered to your inbox, and more info about our products and services.
Jay Woods breaks down the charts in Steris.
David Keller breaks down the technicals on this biotech giant.
Frank Cappelleri of CappThesis breaks down the bullish technical backdrop for this pharma-related stock.
Chart analyst Frank Cappelleri breaks down the technical outlook on the biotech stock.
Katie Stockton breaks down the technical outlook on this telehealth name.
David Keller breaks down the charts in Boston Scientific.
